Valved Sano conduit improves immediate outcomes following Norwood operation compared with nonvalved Sano conduit

J Thorac Cardiovasc Surg. 2024 Apr;167(4):1404-1413. doi: 10.1016/j.jtcvs.2023.08.036. Epub 2023 Sep 4.

Abstract

Objective: Use of a valved Sano during the Norwood procedure has been reported previously, but its impact on clinical outcomes needs to be further elucidated. We assessed the impact of the valved Sano compared with the nonvalved Sano after the Norwood procedure in patients with hypoplastic left heart syndrome.

Methods: We retrospectively reviewed 25 consecutive neonates with hypoplastic left heart syndrome who underwent a Norwood procedure with a valved Sano conduit using a femoral venous homograft and 25 consecutive neonates with hypoplastic left heart syndrome who underwent a Norwood procedure with a nonvalved Sano conduit between 2013 and 2022. Primary outcomes were end-organ function postoperatively and ventricular function over time. Secondary outcomes were cardiac events, all-cause mortality, and Sano and pulmonary artery reinterventions at discharge, interstage, and pre-Glenn time points.

Results: Postoperatively, the valved Sano group had significantly lower peak and postoperative day 1 lactate levels (P = .033 and P = .025, respectively), shorter time to diuresis (P = .043), and shorter time to enteral feeds (P = .038). The valved Sano group had significantly fewer pulmonary artery reinterventions until the Glenn operation (n = 1 vs 8; P = .044). The valved Sano group showed significant improvement in ventricular function from the immediate postoperative period to discharge (P < .001). From preoperative to pre-Glenn time points, analysis of ventricular function showed sustained ventricular function within the valved Sano group, but a significant reduction of ventricular function in the nonvalved Sano group (P = .003). Pre-Glenn echocardiograms showed competent conduit valves in two-thirds of the valved Sano group (n = 16; 67%).

Conclusions: The valved Sano is associated with improved multi-organ recovery postoperatively, better ventricular function recovery, and fewer pulmonary artery reinterventions until the Glenn procedure.

Keywords: PA reintervention; Sano conduit; conduit reintervention; hypoplastic left heart syndrome; mortality; perioperative end-organ recovery; single ventricle function; valved Sano conduit.

MeSH terms

  • Heart Ventricles
  • Humans
  • Hypoplastic Left Heart Syndrome* / surgery
  • Infant, Newborn
  • Norwood Procedures* / adverse effects
  • Norwood Procedures* / methods
  • Prostheses and Implants
  • Pulmonary Artery / diagnostic imaging
  • Pulmonary Artery / surgery
  • Retrospective Studies
  • Treatment Outcome